✦ LIBER ✦

Preclinical and clinical studies of interferons and interferon inducers in breast cancer

✍ Scribed by Ernest C. Borden; Frances R. Balkwill

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 825 KB
Volume: 53
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840201)53:3+<783::aid-cncr2820531329>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carcinoembryonic antigen and interferon

Carcinoembryonic antigen and interferon as tumor markers in breast cancer

✍ Yoav Horn; Dalia Hacohen; Jacob L. Zeidman; Natalio Walach; Sally Sharf; Adi Hel 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

A total of 239 determinations of CEA plasma levels were performed for 83 breast cancer patients during chemotherapy or follow-up. In addition, 137 plasma samples were assayed for interferon levels. Patient clinical status was carefully scored according to objective criteria and recorded at each eval

Clinical overview of alpha interferon. S

Clinical overview of alpha interferon. Studies and future directions

✍ Robert J. Spiegel 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

Clinical and laboratory changes induced

Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia-a pilot study

✍ M. Talpaz; M. Rosenblum; R. Kurzrock; J. Reuben; H. Kantarjian; J. Gutterman 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

Clinical studies of recombinant interfer

Clinical studies of recombinant interferon alfa-2a (Roferon®-A) in cancer patients

✍ Tetsuo Taguchi 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

A Phase I study of interferon alfa-2a was conducted in 20 patients with disseminated cancer to establish the relationship between dose and interferon-related side effects. Fever was the most common side effect, and was not doserelated. Other side effects not related to dose included flu-like symptom

Kinetic, hormonal and clinical studies w

Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer

✍ Richard J. Santen; Eugeniusz Samojlik; Allan Lipton; Harold Harvey; Edward B. Ru 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 932 KB

The clinical and physiological spectrum

The clinical and physiological spectrum of interferon-alpha induced thyroiditis: Toward a new classification

✍ Jamie C. Mandac; Sonal Chaudhry; Kenneth E. Sherman; Yaron Tomer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Interferon -alpha (IFN␣) is a major treatment modality for several malignant and nonmalignant diseases, especially hepatitis C. Prospective studies have shown that up to 15% of patients with hepatitis C receiving IFN␣ develop clinical thyroid disease, and up to 40% were reported to develop thyr